Autopsy report · NCT00936195

Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“faillure to obtain insurance because of refusal from insurance companies”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 3
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Sponsor type: Government (non-US federal)
Conditions: HIV Infection; Pregnancy; Breastfeeding; HIV Infections
Interventions: Efavirenz-Tenofovir-Emtricitabine; Zidovudine-Lamivudine-Lopinavir/Ritonavir
Participants: 0
Sites: 2
Countries: Côte d’Ivoire, Zambia

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.